Constitutively activated STAT3 is correlated with more advanced clinical stage and overall poor survival of diffuse large B-cell lymphoma (DLBCL). The aim of this study was to evaluate STAT3 and Ki67 tumor cell expression, inflammatory cell infiltration, microvascular density in DLBCL bioptic specimens. RNA-scope showed that activated B cell (ABC) tissue samples contained a significant higher number of STAT3+ cells as compared to germinal center B (GCB) tissue samples. Immunohistochemical analysis showed a significant increased levels of CD3, CD8, CD68, CD163, CD34, and Ki67 positive cells in ABC patients. A positive correlation between STAT3 and CD3, CD8, CD68, and CD163 was evidenced in ABC group. In ABC group, we found also a positive co...
Diffuse large B-cell lymphoma (DLBCL) is the most common and one of the most heterogeneous lymphomas...
Background Diffuse large B-cell lymphoma is a clinically and molecularly heterogeneous disease. Gene...
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, is recognized a...
Constitutively activated STAT3 is correlated with more advanced clinical stage and overall poor surv...
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma....
Diffuse large B cell lymphoma (DLBCL) is recognized as the most common form of non-Hodgkin lymphoma ...
Purpose: Activated signal transducer and activator of transcription 3 (STAT3) regulates tumor growth...
The signal transducer and activator of transcription 3 (STAT3) is a key signal transducer that regul...
Activated signal transducer and activator of transcription 3 (STAT3) regulates tumor growth, invasio...
Activated signal transducer and activator of transcription 3 (STAT3) regulates tumor growth, invasio...
The signal transducer and activator of transcription 3 (STAT3) is a transcription factor that, when ...
Background/Aim: MALT type lymphoma belongs to marginal zone lymphoma (MZL). MALT lymphomas' inflamma...
Follicular lymphoma (FL) is a slowly progressive disease and constitutes the second most common non-...
Diffuse Large B-Cell Lymphoma (DLBCL) presents a high clinical and biological heterogeneity, and the...
Persistent STAT3 signaling contributes to malignant progression in many diverse types of human cance...
Diffuse large B-cell lymphoma (DLBCL) is the most common and one of the most heterogeneous lymphomas...
Background Diffuse large B-cell lymphoma is a clinically and molecularly heterogeneous disease. Gene...
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, is recognized a...
Constitutively activated STAT3 is correlated with more advanced clinical stage and overall poor surv...
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma....
Diffuse large B cell lymphoma (DLBCL) is recognized as the most common form of non-Hodgkin lymphoma ...
Purpose: Activated signal transducer and activator of transcription 3 (STAT3) regulates tumor growth...
The signal transducer and activator of transcription 3 (STAT3) is a key signal transducer that regul...
Activated signal transducer and activator of transcription 3 (STAT3) regulates tumor growth, invasio...
Activated signal transducer and activator of transcription 3 (STAT3) regulates tumor growth, invasio...
The signal transducer and activator of transcription 3 (STAT3) is a transcription factor that, when ...
Background/Aim: MALT type lymphoma belongs to marginal zone lymphoma (MZL). MALT lymphomas' inflamma...
Follicular lymphoma (FL) is a slowly progressive disease and constitutes the second most common non-...
Diffuse Large B-Cell Lymphoma (DLBCL) presents a high clinical and biological heterogeneity, and the...
Persistent STAT3 signaling contributes to malignant progression in many diverse types of human cance...
Diffuse large B-cell lymphoma (DLBCL) is the most common and one of the most heterogeneous lymphomas...
Background Diffuse large B-cell lymphoma is a clinically and molecularly heterogeneous disease. Gene...
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma, is recognized a...